Back to Trials
NCT06038409Recruiting

Ketamine Treatment Plans for Chronic Conditions

RIVER Foundation

Start Date

1/1/2023

Completion Date

6/1/2029

Summary

A study aimed to assess the efficacy of the various approaches to prescribing Ketamine currently in use off-label. The focus will be to include ketamine within the study plan of those with chronic conditions who are receiving ketamine.

Detailed Description

Ketamine can be administered in multiple ways (IV, IM, SubQ, and Sublingual, among others), and there have been few if any, studies that have compared the impact of Ketamine at home without any thearpy. The study will identify other treatment modalities used in concurrence with Ketamine. Psychotherapy, music therapy, and acutherapy are some of the most popular. How do these adjunct therapies affect the outcomes of Ketamine treatments? Secondarily, the study will focus on these significant issues to observe the impact of Ketamine treatments and suicidal ideation. Suicidal ideation is multifaceted and is one reason for prescribing off-label Ketamine. Chronic issues such as depression, pain, and anxiety have been identified as underlying causes and may be improvable with Ketamine.

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: Must have an identifiable chronic condition. Exclusion Criteria: Healthy population

Interventions

DRUG

Ketamine

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Chronic PainDepressive DisorderAnxiety DisordersChronic Disease

Locations

RIVER Telehealth

Helena, Montana 59601

United States